telmisartan has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiyo, T; Fujihara, S; Fujita, K; Iwama, H; Kobara, H; Masaki, T; Morishita, A; Okamura, M; Oura, K; Samukawa, E; Tadokoro, T; Yamana, H; Yamana, Y | 1 |
1 other study(ies) available for telmisartan and Pancreatic Neoplasms
| Article | Year |
|---|---|
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Pancreatic Neoplasms; Telmisartan | 2022 |